Botswana vs Niue: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati
Botswana
95.0%
in 2025
Niue
95.0%
in 2025
Botswana rank
38th
Niue rank
38th
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati over time
- Botswana
- Niue
How they compare
Botswana currently reports 95.0% against 95.0% in Niue, a difference of 0.0%.
Across all 18 years both countries report, Niue has been ahead every year.
Botswana ranks 38th and Niue ranks 38th of 194 countries.
Niue has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Botswana | Niue | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 49.5% | 49.5% | Niue |
| 2010s | 66.8% | 99.0% | 32.2% | Niue |
| 2020s | 88.8% | 98.3% | 9.5% | Niue |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati, Botswana or Niue?
- Botswana, at 95.0% against 95.0% in Niue as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati between Botswana and Niue?
- 0.0%, with Botswana ahead.
- How many years of comparable data are there for Botswana and Niue?
- 18 years are reported by both, from 2008 to 2025.
- How do Botswana and Niue rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Botswana ranks 38th and Niue ranks 38th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.